Related Experiment Video

Updated: Oct 3, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage

Jung-Kuang Hsieh1, Damian Yap, Daniel J O'Connor

  • 1Ludwig Institute for Cancer Research, Imperial College School of Medicine, London W2 1PG, United Kingdom.

Molecular and Cellular Biology
|December 12, 2001
PubMed

Insights

DNA damage triggers E2F1 to promote p53

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Cancer Research

Background:

  • The E2F1 transcription factor plays a role in cell cycle regulation and apoptosis.
  • p53 is a tumor suppressor protein crucial for DNA damage response and apoptosis.
  • The interaction between E2F1 and p53 is critical for coordinating cellular responses to DNA damage.

Purpose of the Study:

  • To investigate the mechanism by which E2F1 promotes p53's apoptotic function.
  • To elucidate the role of cyclin A in regulating the E2F1-p53 interaction.
  • To identify a novel role for E2F1 in apoptosis induction following DNA damage.

Main Methods:

  • Co-immunoprecipitation assays to detect protein-protein interactions.
  • Western blotting to analyze protein levels.
  • Apoptosis assays to measure cell death.

Main Results:

  • E2F1 binds to p53 via its cyclin A binding site, enhancing p53's apoptotic function independently of E2F1's DNA binding or transcriptional activity.
  • All cyclin A-binding E2F family members can cooperate with p53 to induce apoptosis.
  • Decreased cyclin A levels during DNA damage correlate with increased E2F1-p53 complex formation, promoting apoptosis.

Conclusions:

  • E2F1 has a novel role in promoting p53-mediated apoptosis in response to DNA damage.
  • The interaction between E2F1 and p53 is regulated by cyclin A levels.
  • Targeting the E2F1-p53 interaction could offer therapeutic strategies for promoting apoptosis in cancer cells.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins10:24

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins

Published on: September 28, 2012

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...